Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-010764
Filing Date
2022-07-15
Accepted
2022-07-15 17:06:21
Documents
6
Effectiveness Date
2022-07-15

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220715xs8.htm S-8 54498
2 EX-5.1 tmb-20220715xex5d1.htm EX-5.1 17653
3 EX-23.2 tmb-20220715xex23d2.htm EX-23.2 3581
4 EX-23.3 tmb-20220715xex23d3.htm EX-23.3 1784
5 EX-FILING FEES tmb-20220715xexfilingfees.htm EX-FILING FEES 25831
6 GRAPHIC tmb-20220715xex5d1001.jpg GRAPHIC 3695
  Complete submission text file 0001558370-22-010764.txt   109602
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266176 | Film No.: 221087523
SIC: 2834 Pharmaceutical Preparations